Advanced Search

Publications > Journals > Future Integrative Medicine > About the journal

Supported by
Capital Medical University
About the journal
Aims and Scope

Future Integrative Medicine (FIM) is the official scientific journal of the Capital Medical University. It is a prominent new journal that promotes future innovation in medicine. FIM publishes high quality peer-reviewed original research, reviews, opinions, commentaries, cases, study protocols, and letters from a wide range of traditional medicine, alternative medicine and complementary medicine. Topics of special interest are conventional medicine, evidence-based medicine, acupuncture, mental health, dietary supplements, and other adjuvant therapy. FIM publishes both basic and clinical research, including but not limited to randomized controlled trials, intervention studies, cohort studies, observational studies, qualitative and mixed method studies, animal studies, and systematic reviews.

Open Access

Future Integrative Medicine (FIM) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.


FIM recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

Publication Criteria

All manuscripts submitted to FIM must meet the following criteria for publication:

  • Topics with timely relevance to the general field or specialties in basic and clinical medicine;
  • A must-have section of “hypothesis/ future direction/ prospect/ prediction” included for all research and review articles;
  • Results and findings that have not been previously published elsewhere;
  • Research performed with adherence to accepted global standards for ethics in the scientific process;
  • Ethical reporting of data to protect the rights and privacy of study participants;
  • Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
  • Conclusions supported by the data presented;
  • All funding sources and their roles cited;
  • For clinical trials, the registration number cited;
  • Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
  • No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.
Publishing Schedule

FIM currently publishes 4 issues a year, in March, June, September and December.

Journal Metrics
FIM Metrics (2023)
Acceptance rate: 22.7% 
Median time from submission to first decision: 17 days 
Median time from acceptance to online publishing: 26 days
Revenue Sources

FIM adopts the open access publishing model. Revenues are generated from article processing charges, permission fees, and reprints.

Contact us
Editorial Office

Managing Editor: Yoko Ye
Postal Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China


Xia & He Publishing Inc.
Tel: +1-409-420-2868 

US Office
Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA

China Office
Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China
Back to Top